Plasma Urate and Risk of Parkinson's Disease
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Oxidative stress contributes to dopaminergic neuron degeneration in Parkinson's disease. Urate, a potent antioxidant, could be neuroprotective. To determine whether higher plasma concentrations of urate predict a reduced risk of Parkinson's disease, the authors conducted a nested case-control study among participants in the Health Professionals Follow-up Study, a cohort comprising over 18,000 men who provided blood samples in 1993-1995. Eighty-four incident cases of Parkinson's disease were diagnosed through 2000, and each was randomly matched to two controls by year of birth, race, and time of blood collection. Rate ratios of Parkinson's disease according to quartile of uricemia were estimated by use of conditional logistic regression. The mean urate concentration was 5.7 mg/dl among cases and 6.1 mg/dl among controls (p = 0.01). After adjustment for age, smoking, and caffeine, the rate ratio of Parkinson's disease for the highest quartile of uricemia compared with the lowest was 0.43 (95% confidence interval: 0.18, 1.02; p(trend) = 0.017). This association was stronger in analyses excluding cases diagnosed within 4 years (median) from blood collection (rate ratio = 0.17, 95% confidence interval: 0.04, 0.69; p(trend) = 0.010). These results suggest that high plasma urate concentrations may decrease the risk of Parkinson's disease, and they raise the possibility that interventions to increase plasma urate may reduce the risk and delay the progression of Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
Prospective study of alcohol consumption and risk of coronary disease in men.
Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., & Stampfer, M. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90542-w · Cited by 1,239 · cited 1×
“The Health Professionals Follow-up Study was established in 1986, when 51,529 male health professionals (dentists, optometrists, pharmacists, osteopaths, podiatrists, and veterinarians), aged 40–75 years, responded to a mailed questionnaire that included a comprehensive diet survey, in addition to questions on disease…”
Self-citationDexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149 · cited 1×
“The oxidative metabolism of dopamine can produce hydrogen peroxide and other reactive oxygen species, as well as conditions favorable to oxidative stress, including increased iron (12, 13 ) and decreased glutathione, and signs of oxidative damage to lipids, proteins, and DNA have been observed in postmortem Parkinson’…”
BackgroundLiberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Self-citationPrzedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
Hooper, D. C., Spitsin, S., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudhry, I., & Koprowski, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.675 · Cited by 569
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
Sofic, E., Paulus, W., Jellinger, K., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 524
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Squadrito, G. L., Cueto, R., Splenser, A. E., Valavanidis, A., Zhang, H., Uppu, R. M., & Pryor, W. A. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1721 · Cited by 364
Serum uric acid levels and the risk of Parkinson disease
de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20663 · Cited by 301
Blood vessels change in the mesencephalon of patients with Parkinson's disease
Faucheux, B. A., Agid, Y., Hirsch, E. C., & Bonnet, A.-M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00641-8 · Cited by 218
Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease
Davis, J. W., Grandinetti, A., Waslien, C. J., Ross, G. W., White, L. R., & Morens, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008954 · Cited by 216
A Reassessment of the Peroxynitrite Scavenging Activity of Uric Acid
WHITEMAN, M., KETSAWATSAKUL, U., & HALLIWELL, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04072.x · Cited by 184
Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation
Church, W. H., & Ward, V. L. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90285-2 · Cited by 173
Tončev, G., Miličić, B., Tončev, S., & Samardžić, G. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.00384.x · Cited by 140
Scott, G. S., Spitsin, S. V., Kean, R. B., Mikheeva, T., Koprowski, H., & Hooper, D. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212645999 · Cited by 128
Comparison of uric acid and ascorbic acid in protection against EAE
Spitsin, S. V., Scott, G. S., Mikheeva, T., Zborek, A., Kean, R. B., Brimer, C. M., Koprowski, H., & Hooper, D. C. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01048-1 · Cited by 125
The role of uric acid in protection against peroxynitrite-mediated pathology
Scott, G. S., & Hooper, D. C. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1118 · Cited by 97
(1984) · PubMed · Cited by 91
Hooper, D. C., Kean, R. B., Scott, G. S., Spitsin, S. V., Mikheeva, T., Morimoto, K., Bette, M., Röhrenbeck, A. M., Dietzschold, B., & Weihe, E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3470 · Cited by 81
Tohgi, H., Abe, T., Takahashi, S., & Kikuchi, T. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02261005 · Cited by 69
Koprowski, H., Spitsin, S. V., & Hooper, D. C. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1<139::aid-ana28>3.0.co;2-a · Cited by 54
Effect of inosine supplementation on aerobic and anaerobic cycling performance
STARLING, R. D., TRAPPE, T. A., SHORT, K. R., SHEFFIELD-MOORE, M., JOZSI, A. C., FINK, W. J., & COSTILL, D. L. (1996) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199609000-00017 · Cited by 53
Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic twins
Spitsin, S. V., Hooper, D. C., Mikheeva, T., & Koprowski, H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700305 · Cited by 49
Anderson, R. F., & Harris, T. A. (2003) · Free Radical Research · doi:10.1080/10715760310001604134 · Cited by 46
Serum uric acid levels in optic neuritis
Knapp, C. M., Constantinescu, C. S., Tan, J. H., McLean, R. J., Cherryman, G. R., & Gottlob, I. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1042oa · Cited by 39
Ilundáin, R. L., Valls, J. V. F., Rueda, J. J. V., Guerrero, D., & Fraile, P. (2001) · Revista Española de Salud Pública · doi:10.1590/s1135-57272001000100006 · Cited by 29
Cited by
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Self-citation2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Dalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Metadata
- Authors
- Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-21
- Volume
- 166
- Issue
- 5
- Pages
- 561-567
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2097939227
- Cited by
- 390
- References
- 35
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.